View ValuationLianhe Chemical TechnologyLtd 향후 성장Future 기준 점검 5/6Lianhe Chemical TechnologyLtd은 연간 수입과 매출이 각각 29.9%와 27.4% 증가할 것으로 예상되고 EPS는 연간 30.3%만큼 증가할 것으로 예상됩니다.핵심 정보29.9%이익 성장률30.30%EPS 성장률Chemicals 이익 성장28.8%매출 성장률27.4%향후 자기자본이익률n/a애널리스트 커버리지Low마지막 업데이트27 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Jul 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥16.50, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 68% over the past three years.Declared Dividend • Jul 04Dividend increased to CN¥0.20Dividend of CN¥0.20 is 900% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 1.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 5.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 30% over the next year, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥15.65, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 57% over the past three years.공고 • Jun 30Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 26, 2026Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 26, 2026Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Gang Chen was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공고 • Apr 24Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 25, 2026Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 25, 2026, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China공고 • Mar 31Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026공고 • Dec 31Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026공고 • Sep 30Lianhe Chemical Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 28, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025공고 • Sep 18Lianhe Chemical Technology Co.,Ltd. Approves Board ElectionsLianhe Chemical Technology Co.,Ltd. at its EGM held on September 16, 2025, approved election of Wang Ping, Peng Yinsheng and He Chun as non-independent directors and Zhang Yun, Fu Lianfang and Chen Gang as independent directors.공고 • Jul 02Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 27, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 27, 2025공고 • Apr 25Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, Jun 09, 2025Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, Jun 09, 2025, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China공고 • Mar 31Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025공고 • Mar 01Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces an Equity Buyback for CNY 80 million worth of its shares.Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its shares. The shares will be repurchased at CNY 9.50 per share. The shares repurchased will be used for employee stock ownership plans or equity incentives. The program will be funded using the company's own funds or self-raised funds. The program is valid for 12 months.공고 • Dec 31Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.031 (vs CN¥0.084 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.031 (up from CN¥0.084 loss in 3Q 2023). Revenue: CN¥1.38b (up 2.1% from 3Q 2023). Net income: CN¥18.3m (up CN¥118.3m from 3Q 2023). Profit margin: 1.3% (up from net loss in 3Q 2023). Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 37 percentage points per year, which is a significant difference in performance.공고 • Sep 30Lianhe Chemical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024공고 • Sep 23Lianhe Chemical Technology Co.,Ltd.(XSEC:002250) dropped from FTSE All-World Index (USD)Lianhe Chemical Technology Co.,Ltd.(XSEC:002250) dropped from FTSE All-World Index (USD)Reported Earnings • Aug 24Second quarter 2024 earnings released: EPS: CN¥0.012 (vs CN¥0.027 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.012 (up from CN¥0.027 loss in 2Q 2023). Revenue: CN¥1.51b (down 12% from 2Q 2023). Net income: CN¥11.5m (up CN¥31.5m from 2Q 2023). Profit margin: 0.8% (up from net loss in 2Q 2023). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 41% per year, which means it has not declined as severely as earnings.Declared Dividend • Jul 08Dividend reduced to CN¥0.02Dividend of CN¥0.02 is 80% lower than last year. Ex-date: 12th July 2024 Payment date: 12th July 2024 Dividend yield will be 0.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.공고 • Jun 29Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024공고 • Apr 29Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 22, 2024Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 22, 2024, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang ChinaReported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.05 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.003 (down from CN¥0.05 in 1Q 2023). Revenue: CN¥1.47b (down 25% from 1Q 2023). Net income: CN¥2.69m (down 94% from 1Q 2023). Profit margin: 0.2% (down from 2.3% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 38% per year, which means it is performing significantly worse than earnings.New Risk • Apr 16New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.공고 • Mar 30Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024New Risk • Mar 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (41% net debt to equity). Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (46% net debt to equity). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥6.07, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 73% over the past three years.공고 • Jan 29Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces an Equity Buyback for CNY 80 million worth of its shares.Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its A shares. The shares will be purchased at a price not exceeding CNY 10 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid for 12 months.공고 • Dec 29Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 30, 2024공고 • Dec 13+ 1 more updateLianhe Chemical Technology Co.,Ltd.(SZSE:002250) dropped from Shenzhen Stock Exchange Component A Share IndexLianhe Chemical Technology Co., Ltd. has been removed from Shenzhen Stock Exchange Component A Share Index .Reported Earnings • Oct 29Third quarter 2023 earnings released: CN¥0.084 loss per share (vs CN¥0.15 profit in 3Q 2022)Third quarter 2023 results: CN¥0.084 loss per share (down from CN¥0.15 profit in 3Q 2022). Revenue: CN¥1.35b (down 39% from 3Q 2022). Net loss: CN¥100.0m (down 172% from profit in 3Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 25Second quarter 2023 earnings released: CN¥0.027 loss per share (vs CN¥0.14 profit in 2Q 2022)Second quarter 2023 results: CN¥0.027 loss per share (down from CN¥0.14 profit in 2Q 2022). Revenue: CN¥1.71b (down 15% from 2Q 2022). Net loss: CN¥20.0m (down 115% from profit in 2Q 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.공고 • Jul 10Lianhe Chemical Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares) , Payment Date Is 14 July 2023Lianhe Chemical Technology Co.,Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) of CNY1.00000000. Record date is 13 July 2023. Ex-date is 14 July 2023.Payment date is 14 July 2023.공고 • Jul 01Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 25, 2023Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 25, 2023공고 • May 20Lianhe Chemical Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2022Lianhe Chemical Technology Co.,Ltd. at the AGM, the shareholders approved a final cash dividend per ten shares (tax included) of CNY 1.00000000 for the year 2022.Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: CN¥0.05 (vs CN¥0.08 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.05 (down from CN¥0.08 in 1Q 2022). Revenue: CN¥1.96b (up 16% from 1Q 2022). Net income: CN¥44.6m (down 40% from 1Q 2022). Profit margin: 2.3% (down from 4.4% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Yun Zhang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.10 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.15 (up from CN¥0.10 in 3Q 2021). Revenue: CN¥2.20b (up 27% from 3Q 2021). Net income: CN¥138.1m (up 56% from 3Q 2021). Profit margin: 6.3% (up from 5.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.11 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.11 in 2Q 2021). Revenue: CN¥2.01b (up 27% from 2Q 2021). Net income: CN¥130.3m (up 24% from 2Q 2021). Profit margin: 6.5% (down from 6.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 19% per year.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Shouyun Yu was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥14.17, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.12 in 3Q 2020)The company reported a mediocre third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.73b (up 32% from 3Q 2020). Net income: CN¥88.5m (down 22% from 3Q 2020). Profit margin: 5.1% (down from 8.7% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.16 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥1.58b (up 10% from 2Q 2020). Net income: CN¥105.0m (down 28% from 2Q 2020). Profit margin: 6.6% (down from 10% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Apr 25Full year 2020 earnings released: EPS CN¥0.12 (vs CN¥0.16 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥4.78b (up 12% from FY 2019). Net income: CN¥110.0m (down 24% from FY 2019). Profit margin: 2.3% (down from 3.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 39% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Jan 21New 90-day high: CN¥26.07The company is up 8.0% from its price of CN¥24.20 on 23 October 2020. The Chinese market is also up 8.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥31.94 per share.Is New 90 Day High Low • Nov 23New 90-day low: CN¥23.39The company is down 8.0% from its price of CN¥25.50 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥27.48 per share.Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥72.8m, down 79% from the prior year. Total revenue was CN¥4.41b over the last 12 months, down 8.2% from the prior year.Is New 90 Day High Low • Oct 22New 90-day low: CN¥24.06The company is down 8.0% from its price of CN¥26.24 on 24 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.63 per share.이익 및 매출 성장 예측XSEC:002250 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202711,230729N/A1,157112/31/20268,955622N/A78513/31/20266,8834146001,062N/A12/31/20256,4303627121,135N/A9/30/20256,0363868431,232N/A6/30/20255,848313507918N/A3/31/20255,7211508071,243N/A12/31/20245,6771036571,237N/A9/30/20245,783-3574081,147N/A6/30/20245,755-4762681,100N/A3/31/20245,950-507-286849N/A12/31/20236,442-465221,077N/A9/30/20236,982279-251933N/A6/30/20237,828517-694820N/A3/31/20238,130667-1,141406N/A12/31/20227,865697-1,092639N/A9/30/20227,749380-605931N/A6/30/20227,276331-4991,028N/A3/31/20226,851306-6081,016N/A12/31/20216,587315-907738N/A9/30/20216,097166-1,342544N/A6/30/20215,676191-5471,261N/A3/31/20215,528231-1831,448N/A12/31/20204,782110-831,379N/A9/30/20204,40773351,397N/A6/30/20204,01614-639625N/A3/31/20203,703-45-1521,005N/A12/31/20194,284144N/A1,051N/A9/30/20194,809349N/A1,235N/A6/30/20194,681270N/A1,165N/A3/31/20194,385129N/A673N/A12/31/20184,11438N/A537N/A9/30/20183,80816N/A227N/A6/30/20183,99042N/A431N/A3/31/20184,260183N/A517N/A12/31/20174,107205N/A589N/A9/30/20173,717195N/A530N/A6/30/20173,264186N/A384N/A3/31/20173,021240N/A427N/A12/31/20163,099264N/A548N/A9/30/20163,319445N/A574N/A6/30/20163,858582N/A672N/A3/31/20164,029593N/A722N/A12/31/20154,008638N/A645N/A9/30/20154,065616N/A696N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002250 의 연간 예상 수익 증가율(29.9%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002250 의 연간 수익(29.9%)이 CN 시장(26%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 002250 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 002250 의 수익(연간 27.4%)이 CN 시장(연간 16%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 002250 의 수익(연간 27.4%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002250의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/24 20:34종가2026/07/24 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Lianhe Chemical Technology Co.,Ltd.는 10명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xiaofeng QiuChina International Capital Corporation LimitedXiling LiChina International Capital Corporation LimitedAda WangChina Stock Investment Research Co. Ltd. (DeepValue.online)7명의 분석가 더 보기
Valuation Update With 7 Day Price Move • Jul 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥16.50, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 68% over the past three years.
Declared Dividend • Jul 04Dividend increased to CN¥0.20Dividend of CN¥0.20 is 900% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 1.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 5.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 30% over the next year, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥15.65, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 57% over the past three years.
공고 • Jun 30Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 26, 2026Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 26, 2026
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Gang Chen was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공고 • Apr 24Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 25, 2026Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 25, 2026, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China
공고 • Mar 31Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026
공고 • Dec 31Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026
공고 • Sep 30Lianhe Chemical Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 28, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025
공고 • Sep 18Lianhe Chemical Technology Co.,Ltd. Approves Board ElectionsLianhe Chemical Technology Co.,Ltd. at its EGM held on September 16, 2025, approved election of Wang Ping, Peng Yinsheng and He Chun as non-independent directors and Zhang Yun, Fu Lianfang and Chen Gang as independent directors.
공고 • Jul 02Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 27, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 27, 2025
공고 • Apr 25Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, Jun 09, 2025Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, Jun 09, 2025, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China
공고 • Mar 31Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
공고 • Mar 01Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces an Equity Buyback for CNY 80 million worth of its shares.Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its shares. The shares will be repurchased at CNY 9.50 per share. The shares repurchased will be used for employee stock ownership plans or equity incentives. The program will be funded using the company's own funds or self-raised funds. The program is valid for 12 months.
공고 • Dec 31Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025
Reported Earnings • Oct 31Third quarter 2024 earnings released: EPS: CN¥0.031 (vs CN¥0.084 loss in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.031 (up from CN¥0.084 loss in 3Q 2023). Revenue: CN¥1.38b (up 2.1% from 3Q 2023). Net income: CN¥18.3m (up CN¥118.3m from 3Q 2023). Profit margin: 1.3% (up from net loss in 3Q 2023). Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 37 percentage points per year, which is a significant difference in performance.
공고 • Sep 30Lianhe Chemical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
공고 • Sep 23Lianhe Chemical Technology Co.,Ltd.(XSEC:002250) dropped from FTSE All-World Index (USD)Lianhe Chemical Technology Co.,Ltd.(XSEC:002250) dropped from FTSE All-World Index (USD)
Reported Earnings • Aug 24Second quarter 2024 earnings released: EPS: CN¥0.012 (vs CN¥0.027 loss in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.012 (up from CN¥0.027 loss in 2Q 2023). Revenue: CN¥1.51b (down 12% from 2Q 2023). Net income: CN¥11.5m (up CN¥31.5m from 2Q 2023). Profit margin: 0.8% (up from net loss in 2Q 2023). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 41% per year, which means it has not declined as severely as earnings.
Declared Dividend • Jul 08Dividend reduced to CN¥0.02Dividend of CN¥0.02 is 80% lower than last year. Ex-date: 12th July 2024 Payment date: 12th July 2024 Dividend yield will be 0.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.
공고 • Jun 29Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024
공고 • Apr 29Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 22, 2024Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 22, 2024, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China
Reported Earnings • Apr 28First quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.05 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.003 (down from CN¥0.05 in 1Q 2023). Revenue: CN¥1.47b (down 25% from 1Q 2023). Net income: CN¥2.69m (down 94% from 1Q 2023). Profit margin: 0.2% (down from 2.3% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 38% per year, which means it is performing significantly worse than earnings.
New Risk • Apr 16New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
공고 • Mar 30Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024
New Risk • Mar 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (41% net debt to equity). Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
New Risk • Feb 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (46% net debt to equity). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥6.07, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 73% over the past three years.
공고 • Jan 29Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces an Equity Buyback for CNY 80 million worth of its shares.Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its A shares. The shares will be purchased at a price not exceeding CNY 10 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid for 12 months.
공고 • Dec 29Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 30, 2024
공고 • Dec 13+ 1 more updateLianhe Chemical Technology Co.,Ltd.(SZSE:002250) dropped from Shenzhen Stock Exchange Component A Share IndexLianhe Chemical Technology Co., Ltd. has been removed from Shenzhen Stock Exchange Component A Share Index .
Reported Earnings • Oct 29Third quarter 2023 earnings released: CN¥0.084 loss per share (vs CN¥0.15 profit in 3Q 2022)Third quarter 2023 results: CN¥0.084 loss per share (down from CN¥0.15 profit in 3Q 2022). Revenue: CN¥1.35b (down 39% from 3Q 2022). Net loss: CN¥100.0m (down 172% from profit in 3Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 25Second quarter 2023 earnings released: CN¥0.027 loss per share (vs CN¥0.14 profit in 2Q 2022)Second quarter 2023 results: CN¥0.027 loss per share (down from CN¥0.14 profit in 2Q 2022). Revenue: CN¥1.71b (down 15% from 2Q 2022). Net loss: CN¥20.0m (down 115% from profit in 2Q 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.
공고 • Jul 10Lianhe Chemical Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares) , Payment Date Is 14 July 2023Lianhe Chemical Technology Co.,Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) of CNY1.00000000. Record date is 13 July 2023. Ex-date is 14 July 2023.Payment date is 14 July 2023.
공고 • Jul 01Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 25, 2023Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 25, 2023
공고 • May 20Lianhe Chemical Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2022Lianhe Chemical Technology Co.,Ltd. at the AGM, the shareholders approved a final cash dividend per ten shares (tax included) of CNY 1.00000000 for the year 2022.
Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: CN¥0.05 (vs CN¥0.08 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.05 (down from CN¥0.08 in 1Q 2022). Revenue: CN¥1.96b (up 16% from 1Q 2022). Net income: CN¥44.6m (down 40% from 1Q 2022). Profit margin: 2.3% (down from 4.4% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Yun Zhang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.10 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.15 (up from CN¥0.10 in 3Q 2021). Revenue: CN¥2.20b (up 27% from 3Q 2021). Net income: CN¥138.1m (up 56% from 3Q 2021). Profit margin: 6.3% (up from 5.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.11 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.11 in 2Q 2021). Revenue: CN¥2.01b (up 27% from 2Q 2021). Net income: CN¥130.3m (up 24% from 2Q 2021). Profit margin: 6.5% (down from 6.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 19% per year.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Shouyun Yu was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥14.17, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.12 in 3Q 2020)The company reported a mediocre third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.73b (up 32% from 3Q 2020). Net income: CN¥88.5m (down 22% from 3Q 2020). Profit margin: 5.1% (down from 8.7% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.16 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥1.58b (up 10% from 2Q 2020). Net income: CN¥105.0m (down 28% from 2Q 2020). Profit margin: 6.6% (down from 10% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Apr 25Full year 2020 earnings released: EPS CN¥0.12 (vs CN¥0.16 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥4.78b (up 12% from FY 2019). Net income: CN¥110.0m (down 24% from FY 2019). Profit margin: 2.3% (down from 3.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 39% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Jan 21New 90-day high: CN¥26.07The company is up 8.0% from its price of CN¥24.20 on 23 October 2020. The Chinese market is also up 8.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥31.94 per share.
Is New 90 Day High Low • Nov 23New 90-day low: CN¥23.39The company is down 8.0% from its price of CN¥25.50 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥27.48 per share.
Reported Earnings • Nov 01Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥72.8m, down 79% from the prior year. Total revenue was CN¥4.41b over the last 12 months, down 8.2% from the prior year.
Is New 90 Day High Low • Oct 22New 90-day low: CN¥24.06The company is down 8.0% from its price of CN¥26.24 on 24 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.63 per share.